Home › Metastatic Cancer › New York › Syracuse
Metastatic Cancer clinical trials in Syracuse, NY
3 studies for Metastatic Cancer are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- State University of New York Upstate Medical University, Syracuse
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Hematology-Oncology Associates of Central New York, PC, East Syracuse · 4 mi away
- Hematology-Oncology Associates of Central New York, PC, Camillus · 8 mi away
- Hematology-Oncology Associates of Central New York, PC, Auburn · 23 mi away
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Hematology Oncology Associates of Central New York, East Syracuse · 4 mi away
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Syracuse
- Non-Small Cell Lung Cancer15 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Non-Muscle Invasive Bladder Cancer8 studies
- Ovarian Cancer7 studies
- Endometrial Cancer7 studies
- Obesity6 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Macular Degeneration5 studies
- Acute Myeloid Leukemia5 studies
- Type 2 Diabetes5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.